标题
Antibiotics in development targeting protein synthesis
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1241, Issue 1, Pages 122-152
出版商
Wiley
发表日期
2011-12-23
DOI
10.1111/j.1749-6632.2011.06323.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa
- (2011) Glenn A. Pankuch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
- (2011) Robert T. Cass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEfficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models
- (2011) Noe Reyes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
- (2011) J. Gordon Still et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cethromycin-Mediated Protection against the Plague Pathogen Yersinia pestis in a Rat Model of Infection and Comparison with Levofloxacin
- (2011) Jason A. Rosenzweig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteriophages Carrying Antibiotic Resistance Genes in Fecal Waste from Cattle, Pigs, and Poultry
- (2011) Marta Colomer-Lluch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New antimicrobial agents on the horizon
- (2011) Karen Bush et al. BIOCHEMICAL PHARMACOLOGY
- Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital
- (2011) Chih-Ming Chen et al. BMC MICROBIOLOGY
- Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects
- (2011) J. G. Still et al. CLINICAL INFECTIOUS DISEASES
- Efforts to Support the Development of Fusidic Acid in the United States
- (2011) P. Fernandes et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2011) J. Carl Craft et al. CLINICAL INFECTIOUS DISEASES
- Application of Pharmacokinetic-Pharmacodynamic Modeling and the Justification of a Novel Fusidic Acid Dosing Regimen: Raising Lazarus From the Dead
- (2011) Brian T. Tsuji et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antimicrobial Findings for Fusidic Acid Tested Against Contemporary (2008–2009) Gram-Positive Organisms Collected in the United States
- (2011) Ronald N. Jones et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of the pharmacokinetics–pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection
- (2011) Olanrewaju O. Okusanya et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
- (2011) Fred C. Tenover et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection
- (2010) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
- (2010) D. Bertrand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
- (2010) B. Llano-Sotelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CEM-101 Activity against Gram-Positive Organisms
- (2010) L. N. Woosley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
- (2010) S. D. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
- (2010) G. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102)
- (2010) Douglas J. Biedenbach et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM
- (2010) M. Galimand et al. RNA
- In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
- (2009) P. M. Roblin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
- (2009) K. B. Waites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
- (2009) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
- (2009) Shannon D. Putnam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines
- (2009) S. Lemaire et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008
- (2009) S. N. Patel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- R -01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
- (2008) E. Skripkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin
- (2008) V. A. Luna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now